Opendata, web and dolomites

INVADERS SIGNED

Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INVADERS project word cloud

Explore the words cloud of the INVADERS project. It provides you a very rough idea of what is the project "INVADERS" about.

promotion    host    epidemic    homeostasis    cardiovascular    herein    relationship    health    public    provides    models    microbiota    food    ultimately    characterization    stably    abnormalities    chronic    steatosis    hyperlipidemia    metabolic    encroachment    alter    humanity    inner    maintained    intestinal    resistance    investigation    additives    protect    inflammatory    reported    disorders    disease    insulin    penetrating    altogether    disturbance    diverse    hypothesis    safe    tract    grade    penetrate    alterations    care    emulsifiers    drive    class    counteract    original    collectively    threatens    ubiquitous    incidence    genetic    community    modulate    therapeutic    invaders    clinical    previously    epithelial    appropriately    inter    preclinical    obesity    downstream    mechanisms    world    promoted    distance    diseases    monolayer    mucus    benefits    hepatic    bacteria    hyperglycemia    central    morbid    ing    mechanism    costly    overwhelm    cell    inflammation    economies    detrimentally    dire    inhabited    layer   

Project "INVADERS" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 1˙850˙000 €
 EC max contribution 1˙850˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2024-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 1˙850˙000.00

Map

 Project objective

Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease

Humanity is facing an epidemic of inter-related metabolic disorders, including obesity, insulin resistance, hyperglycemia, hyperlipidemia, and hepatic steatosis, that altogether have major impact on the promotion of cardiovascular diseases. The increasing incidence of these complex metabolic disorders and their highly morbid, chronic and costly downstream diseases threatens to overwhelm the world’s health care systems and economies, making it a top public health priority in dire need of investigation. The intestinal tract is inhabited by a large and diverse community of bacteria, collectively referred to as the intestinal microbiota. When stably maintained at an appropriately safe distance from the epithelial cell monolayer, the microbiota provides important benefits to its host. However, disturbance of the microbiota-host relationship, promoted by genetic or non-genetic factors, can alter intestinal homeostasis and drive chronic low-grade intestinal inflammation, ultimately leading to metabolic abnormalities. We previously reported that a ubiquitous class of food additives, emulsifiers, detrimentally impact the microbiota resulting in its encroachment into the mucus layer that associated with low-grade inflammation and development of metabolic disorders. The central goal of this proposal is to investigate the hypothesis that bacteria that penetrate the inner part of the mucus layer, referred as invaders, promote development of metabolic alterations. We herein propose to identify mucus-invaders, in preclinical models and clinical conditions, and investigate mechanisms by which they promote inflammatory and metabolic abnormalities. Furthermore, we propose to define original approaches to modulate the intestinal microbiota in order to counteract microbiota encroachment and protect against associated metabolic abnormalities.

 Publications

year authors and title journal last update
List of publications.
2019 Hao Q. Tran, Ruth E. Ley, Andrew T. Gewirtz, Benoit Chassaing
Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-13538-y
Nature Communications 10/1 2020-02-05

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INVADERS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INVADERS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ENUF (2019)

Evaluation of Novel Ultra-Fast selective III-V Epitaxy

Read More  

Diverge (2019)

Generation of ultra-deep libraries of transcriptional activators for gene therapy

Read More  

Aware (2019)

Aiding Antibiotic Development with Deep Analysis of Resistance Evolution

Read More